Hologic today said it received FDA approval for its 3DQuorum Imaging Technology that is powered by the company’s Genius AI.
The imaging technology works with Hologic’s Clarity HD high-resolution imaging technology to reduce tomosynthesis image volume for radiologists. Using Genius AI-powered analytics, 3DQuorum reconstructs high-resolution 3D data to make 6mm “SmartSlices.” The analytics help doctors identify clinically relevant regions of interest while preserving important features in the reconstruction of SmartSlices.
The 3DQuorum technology reduces the number of 3D images needed to review by two-thirds.
“Superior breast cancer detection begins with our superior imaging, and only Hologic offers a comprehensive breast health ecosystem that improves outcomes, reduces costs and increases patient and clinician satisfaction,” Pete Valenti, Hologic division president of breast and skeletal health solutions, said in a news release. “3DQuorum technology is the first of many products to come powered by our new Genius AI technology platform, which will further revolutionize cancer detection in the coming years. 3DQuorum technology delivers meaningful productivity gains for radiologists due to a significant reduction in read time.”
Hologic’s 3DQuorum technology is available through the company’s Clarity HD Plus technology and can be used with existing and future Hologic 3D mammography systems.
